Englumafusp Alfa (CD19-4-1BBL) and Glofitamab Combination in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL): Biomarker Results from a Phase I Dose-Escalation Trial
Disclosures. Korfi:Roche Glycart/Roche: Current Employment, Current equity holder in publicly-traded company. Christiansen:Roche: Consultancy. Jiang:ROCHE: Curr